Potential treatments for epigenetic dysregulation in neurological diseases

Potential treatments for epigenetic dysregulation in neurological diseases

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografische gegevens
Hoofdauteur:	Zaman, Rubaiyat
Andere auteurs:	Sharmin, Sabrina
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2024
Onderwerpen:	Epigenetics Methylation Parkinson’s disease Alzheimer’s disease Huntington’s disease Acetylation Nervous System Diseases Epigenesis
Online toegang:	http://hdl.handle.net/10361/23157

Gelijkaardige items

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
door: Mostofa, Golam
Gepubliceerd in: (2022)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
door: Dey, Manashi
Gepubliceerd in: (2024)

Role of epigenetics in the development of metabolic disorders: a review
door: Mita, Tanzia Mohsin
Gepubliceerd in: (2024)

Role of circular RNA in neurological disease
door: Salsabil, Labiba
Gepubliceerd in: (2024)

Gene editing for neurodegenerative diseases-A review
door: Sharna, Anika Islam
Gepubliceerd in: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
door: Alim, Abdul
Gepubliceerd in: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
door: Annee, Israt Jahan
Gepubliceerd in: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
door: Afsana, Nourin
Gepubliceerd in: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
door: Chowdhury, Sariya Uzrat
Gepubliceerd in: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
door: Ferdous, Labiba
Gepubliceerd in: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
door: Bakar, Osama Bin Abu
Gepubliceerd in: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
door: Tabassum, Nadira
Gepubliceerd in: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
door: Islam, Md. Irfath
Gepubliceerd in: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
door: Shehab, Habibul Mohsin
Gepubliceerd in: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
door: Afreen, Nuraia
Gepubliceerd in: (2021)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
door: Karmaker, Swastika
Gepubliceerd in: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
door: Key, Nasrin Sultana
Gepubliceerd in: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
door: Tamanna, Mst. Taskia
Gepubliceerd in: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
door: Tasneem, Sadia
Gepubliceerd in: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
door: Ishrat, Nowshin
Gepubliceerd in: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
door: Saha, Bithi Rani
Gepubliceerd in: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
door: Chowdhury, Amal
Gepubliceerd in: (2024)

A review on cardiovascular development and epigenetics
door: Srity, Nafisa Alam
Gepubliceerd in: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
door: Hassan, Md. Muhtaz
Gepubliceerd in: (2020)

Marine compounds in the treatment of Alzheimer’s disease
door: Parveen, Sanjana
Gepubliceerd in: (2022)

Alzheimer's disease and marriage : an intimate account /
door: Wright, Lore K.
Gepubliceerd in: (1993)

Review on: the mechanism and function of Glia in parkinson's disease
door: Abedin, Khondokar Mezbahul
Gepubliceerd in: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
door: Tasin, Md Abtahi
Gepubliceerd in: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
door: Aziz, Farhin
Gepubliceerd in: (2019)

Infection and communicable diseases /
door: Brettle, Raymond Patrick
Gepubliceerd in: (1984)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
door: Afra, Sumaiya
Gepubliceerd in: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
door: Mahee, Sadique Abdal
Gepubliceerd in: (2024)

Early detection of parkinson’s disease using image processing and artificial neural network
door: Rumman, Mosarrat, et al.
Gepubliceerd in: (2018)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
door: Rawshan, A. E. Maisha
Gepubliceerd in: (2022)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
door: Nayeem, Abdullah Al
Gepubliceerd in: (2021)

Control of communicable diseases manual : an official report of the American Public Health Association /
Gepubliceerd in: (1995)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
door: Islam, Md. Rakibul
Gepubliceerd in: (2023)

Clinical Infectious Diseases

The Journal of Infectious Diseases

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
door: Halim, Rabea
Gepubliceerd in: (2022)